Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial - a podcast by European Society of Cardiology

from 2020-08-31T14:35:23

:: ::

With Renato Lopes, Duke Univ. Medical Center - U.S. and Alexander Fanaroff, Univ. of Pennsylvania - U.S.